Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Laura Gamble.

Newcastle AuthorsTitleYearFull text
Dr Laura Gamble
Dr Holly Bennett
Professor Fiona Matthews
A comparison of well-being of carers of people with dementia and their ability to manage before and during the COVID-19 pandemic: findings from the IDEAL study 2022
Dr Laura Gamble
Professor Fiona Matthews
Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study2022
Dr Laura Gamble
Professor Fiona Matthews
Longitudinal trajectories of quality of life among people with mild-to-moderate dementia: a latent growth model approach with IDEAL cohort study data2022
Dr Holly Bennett
Dr Laura Gamble
Professor Fiona Matthews
Minimal Impact of COVID-19 Pandemic on the Mental Health and Wellbeing of People Living With Dementia: Analysis of Matched Longitudinal Data From the IDEAL Study2022
Dr Laura Gamble
Dr Yu-Tzu Wu
Professor Fiona Matthews
The Use and Costs of Paid and Unpaid Care for People with dementia: Longitudinal Findings from the IDEAL cohort2022
Dr Laura Gamble
Dr Louise Allan
Professor Fiona Matthews
Impact of COVID-19 on 'living well' with mild-to-moderate dementia in the community: findings from the IDEAL cohort2021
Dr Laura Gamble
Professor Fiona Matthews
Psychological processes in adapting to dementia: illness representations among the IDEAL cohort2021
Dr Laura Gamble
Trajectories of socio-emotional functioning in early-stage dementia: implications for the individual with dementia and their family carer2021
Dr Laura Gamble
Professor Fiona Matthews
Living Alone with Mild-To-Moderate Dementia: Findings from the IDEAL Cohort2020
Dr Laura Gamble
Targeting Metabolic Activity in High-Risk Neuroblastoma Through Monocarboxylate Transporter 1 (MCT1) Inhibition2020
Dr Laura Gamble
Inhibition of Polyamine Synthesis and Uptake Reduces Tumor Progression and Prolongs Survival in Mouse Models of Neuroblastoma2019
Livingstone Fultang
Dr Laura Gamble
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma2019
Dr Laura Gamble
Suppression of the ATP-binding Cassette Transporter ABCC4 Impairs Neuroblastoma Tumour Growth and Sensitises to Irinotecan in Vivo2017
Dr Laura Gamble
MYCN Promotes Neuroblastoma Malignancy by Establishing a Regulatory Circuit With Transcription Factor AP42016
Dr Laura Gamble
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression2016
Dr Laura Gamble
Therapeutic Targeting of the MYC Signal by Inhibition of Histone Chaperone FACT in Neuroblastoma2015
Dr Jane Carr-Wilkinson
Bojidar Goranov
Dr Chris Redfern
Dr Laura Gamble
Professor John Lunec
et al.
Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression2011
Dr Lindi Chen
Dr Laura Gamble
Professor John Lunec
Professor Deborah Tweddle
p53 is a direct transcriptional target of MYCN in neuroblastoma2010